Yuko Ishizaka
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Epidemiology top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Nephrology top 1%
- Co-authors
- Minoru YamakadoNobukazu IshizakaRyozo NagaiEi-Ichi TodaMiho TanakaKenji KangawaTanenao EtoHideki Hashimoto
- Topics
- Liver Disease Diagnosis and Treatment (18 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers)Cardiovascular Health and Disease Prevention (13 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Yuko Ishizaka
66 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 112
- Cardiology and Cardiovascular Medicine 693
- Molecular Biology 689
- Epidemiology 673
- Endocrinology, Diabetes and Metabolism 549
- Nephrology 496
Countries citing papers authored by Yuko Ishizaka
This map shows the geographic impact of Yuko Ishizaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Ishizaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Ishizaka more than expected).
Fields of papers citing papers by Yuko Ishizaka
This network shows the impact of papers produced by Yuko Ishizaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Ishizaka. The network helps show where Yuko Ishizaka may publish in the future.
Co-authorship network of co-authors of Yuko Ishizaka
This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Ishizaka. A scholar is included among the top collaborators of Yuko Ishizaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Ishizaka. Yuko Ishizaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Clinical Characteristics of a Japanese Subpopulation with Low Plasma Free Essential and Semi-essential Amino Acid Levels | 1 |
| 3 | Study on Usefulness of AminoIndex Cancer Screening as a Novel Cancer Screening Method-Third Report- | 3 |
| 4 | 17 | |
| 5 | 139 | |
| 6 | 13 | |
| 7 | 45 | |
| 8 | 150 | |
| 9 | 13 | |
| 10 | 28 | |
| 11 | 41 | |
| 12 | 1 | |
| 13 | 24 | |
| 14 | 32 | |
| 15 | 94 | |
| 16 | 0 | |
| 17 | 79 | |
| 18 | 12 | |
| 19 | 55 | |
| 20 | Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs. | 6 |
About Yuko Ishizaka
Yuko Ishizaka is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 68 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Cardiovascular Health and Disease Prevention (13 papers). The work is most often cited by research in Nephrology (496 citations), Endocrinology, Diabetes and Metabolism (549 citations) and Cardiology and Cardiovascular Medicine (693 citations). Yuko Ishizaka has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Minoru Yamakado, Nobukazu Ishizaka, Ryozo Nagai, Ei-Ichi Toda, Miho Tanaka, Kenji Kangawa, Tanenao Eto, Hideki Hashimoto, Mizuki Tani and Akiko Toda. Their work appears in journals such as Circulation, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.